CSIMarket
 

Sight Sciences Inc   (SGHT)
Other Ticker:  
 

Sight Sciences Inc 's Working Capital Per Sales

SGHT's Working Capital and Revenue growth



SGHT Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change -22.31 % -24.66 % -26.63 % -27.2 % -26.15 %
Y / Y Revenue Change 3.51 % 34.02 % 26.5 % - 42.56 %
Working Capital Per Revenue 2.13 2.29 2.65 3.03 9.3
Total Ranking # 2888 # 2893 # 2160 # 2972 # 2893
Seq. Working Capital Change -5.37 % -5.74 % -6.96 % -6.39 % -8.23 %
Seq. Revenue Change -16.28 % 22.66 % -8.37 % 10 % 8.4 %





Comment on SGHT's Working Capital Per Revenue in the third quarter 2023
Sight Sciences Inc 's Working Capital Per Revenue in the Q3 2023 sequentially fell to 2.13 a new company low.

Within Healthcare sector 86 other companies have achieved lower Working Capital Per Revenue during the Q3 2023. While Sight Sciences Inc Working Capital Per Revenue overall ranking has impoved so far in the Q3 2023 to 2888, from total ranking in the second quarter 2023 at 2893.
Working Capital Per Revenue Ranking
Within: No.
Industry # 17
Sector # 87
S&P 500 # 2888


Working Capital Per Revenue Statistics
High Average Low
13.77
6.58
2.13
(Mar 31 2022)   (Sep 30 2023)



Financial Statements
Sight Sciences Inc 's Working Capital $ 159 Millions Visit SGHT's Balance sheet
Sight Sciences Inc 's Revenues $ 19 Millions Visit SGHT's Income Statement
Where are SGHT's Sales coming from? Visit SGHT's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Maxcyte inc   5.83 
Alector Inc   5.69 
Arbutus Biopharma Corp  5.62 
Zevra Therapeutics Inc   5.59 
Inspiremd Inc   5.59 
Rapid Micro Biosystems Inc   5.51 
Zomedica Corp   5.42 
Merus N v   5.30 
Cara Therapeutics inc   5.28 
Hookipa Pharma inc   5.21 
Orchard Therapeutics Plc  5.14 
Mersana Therapeutics inc   5.08 
Alpine Immune Sciences Inc   5.07 
Werewolf Therapeutics Inc   4.94 
Arvinas Inc   4.90 
Xenetic Biosciences Inc   4.88 
Uniqure N v   4.67 
Nektar Therapeutics  4.66 
Aligos Therapeutics Inc   4.59 
Prothena Corporation Public Limited Company  4.55 
Liquidia Corporation  4.48 
Eiger Biopharmaceuticals Inc   4.38 
Universal Biosensors Inc   4.37 
Repare Therapeutics Inc   4.34 
Perspective Therapeutics Inc   3.99 
Rhythm Pharmaceuticals inc   3.98 
Theravance Biopharma inc   3.96 
Pacific Biosciences Of California Inc   3.95 
Siga Technologies Inc  3.94 
Enanta Pharmaceuticals Inc  3.91 
Date modified: 2023-11-08T18:28:58+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com